HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
401	24909 Witt SN Hsp70 Molecular Chaperones and Parkinson's Disease BIOPOLYMERS. 2010 MAR; 93 (3): 218-228	3	6	60	111
402	25681 Goedert M, Clavaguera F, Tolnay M The propagation of prion-like protein inclusions in neurodegenerative diseases TRENDS IN NEUROSCIENCES. 2010 JUL; 33 (7): 317-325	2	3	60	109
403	4079 Wischik CM, Harrington CR, Mena R Molecular determinants of paired helical filament assembly and its therapeutic implications in Alzheimer's disease INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 299-338	2	2	59	212
404	7818 Heutink P Untangling tau-related dementia HUMAN MOLECULAR GENETICS. 2000; 9 (6): 979-986	58	69	59	76
405	10108 Lee MK, Price DL Advances in genetic models of Parkinson's disease CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 456-466	5	8	59	178
406	10858 Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, et al. Regulation of tau phosphorylation and protection against beta-amyloid- induced neurodegeneration by lithium. Possible implications for Alzheimer's disease BIPOLAR DISORDERS. 2002 JUN; 4 (3): 153-165	14	52	59	135
407	13249 Palomo T, Archer T, Beninger RJ, Kostrzewa RM Gene-environment interplay in Neurogenesis and neurodegeneration NEUROTOXICITY RESEARCH. 2004; 6 (6): 415-434	1	8	59	309
408	18154 Windisch M, Wolf HJ, Hutter-Paier B, Wronski R Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders? CURRENT ALZHEIMER RESEARCH. 2007; 4 (5): 556-561	1	2	59	67
409	21616 Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, et al. Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases PLOS ONE. 2008 SEP 4; 3 (9): Art. No. e3135	14	18	59	113
410	23528 Schapira AHV Etiology and Pathogenesis of Parkinson Disease NEUROLOGIC CLINICS. 2009 AUG; 27 (3): 583-+	2	14	59	182
#	Date / Author / Journal	LCS	GCS	LCR	CR
411	24308 Lovestone S, Killick R Is Alzheimer's a Disorder of Ageing and Why Don't Mice get it? The Centrality of Insulin Signalling to Alzheimer's Disease Pathology DIABETES, INSULIN AND ALZHEIMER'S DISEASE. 2010; : 129-152	0	0	59	157
412	24406 Amadoro G, Corsetti V, Stringaro A, Colone M, D'Aguanno S, et al. A NH2 Tau Fragment Targets Neuronal Mitochondria at AD Synapses: Possible Implications for Neurodegeneration JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (2): 445-470	0	0	59	173
413	25225 Ramsey CP, Tsika E, Ischiropoulos H, Giasson BI DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity HUMAN MOLECULAR GENETICS. 2010 APR 15; 19 (8): 1425-1437	1	1	59	106
414	3010 Trojanowski JQ, Lee VMY PHOSPHORYLATION OF NEURONAL CYTOSKELETAL PROTEINS IN ALZHEIMERS-DISEASE AND LEWY BODY DEMENTIAS CALCIUM HYPOTHESIS OF AGING AND DEMENTIA. 1994; 747: 92-109	55	55	58	111
415	10270 Kowalska A Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118	3	3	58	81
416	11314 Echeverria V, Cuello AC Intracellular A-beta amyloid, a sign for worse things to come? MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 299-316	12	41	58	188
417	11666 Bonini NM, Fortini ME Human neurodegenerative disease modeling using Drosophila ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656	26	66	58	178
418	12129 Kaplan B, Ratner V, Haas E alpha-Synuclein - Its biological function and role in neurodegenerative diseases JOURNAL OF MOLECULAR NEUROSCIENCE. 2003 APR; 20 (2): 83-92	11	22	58	93
419	12874 Dawson TM, Dawson VL Molecular pathways of neurodegeneration in Parkinson's disease SCIENCE. 2003 OCT 31; 302 (5646): 819-822	220	603	58	81
420	13098 Sobow T, Flirski M, Liberski PP Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease ACTA NEUROBIOLOGIAE EXPERIMENTALIS. 2004; 64 (1): 53-70	9	17	58	141
#	Date / Author / Journal	LCS	GCS	LCR	CR
421	13867 Uversky VN, Fink AL Conformational constraints for amyloid fibrillation: the importance of being unfolded BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2004 MAY 6; 1698 (2): 131-153	59	384	58	301
422	13955 Zhang J, Goodlett DR Proteomic approach to studying Parkinson's disease MOLECULAR NEUROBIOLOGY. 2004 JUN; 29 (3): 271-288	10	20	58	171
423	14970 Lim JN, Lu KP Pinning down phosphorylated tau and tauopathies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 311-322	10	31	58	129
424	15140 Maingay M, Romero-Ramos M, Kirik D Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: A new model for Parkinson's disease CNS SPECTRUMS. 2005 MAR; 10 (3): 235-244	6	10	58	99
425	15370 Fornai F, Soldani P, Lazzeri G, di Poggio AB, Biagioni F, et al. Neuronal inclusions in degenerative disorders - Do they represent static features or a key to understand the dynamics of the disease? BRAIN RESEARCH BULLETIN. 2005 APR 30; 65 (4): 275-290	2	8	58	133
426	15565 Hoerndli F, David DC, Gotz J Functional genomics meets neurodegenerative disorders Part II: Application and data integration PROGRESS IN NEUROBIOLOGY. 2005 JUN; 76 (3): 169-188	13	21	58	146
427	16159 Neary D, Snowden J, Mann D Frontotemporal dementia LANCET NEUROLOGY. 2005 NOV; 4 (11): 771-780	83	132	58	141
428	16208 Shults CW, Rockenstein E, Crews L, Adame A, Mante M, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: Implications for multiple system atrophy JOURNAL OF NEUROSCIENCE. 2005 NOV 16; 25 (46): 10689-10699	28	32	58	81
429	16870 Abou-Sleiman PM, Muqit MMK, Wood NW Expanding insights of mitochondrial dysfunction in Parkinson's disease NATURE REVIEWS NEUROSCIENCE. 2006 MAR; 7 (3): 207-219	68	246	58	142
430	17177 Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, et al. Small molecule inhibitors of alpha-synuclein filament assembly BIOCHEMISTRY. 2006 MAY 16; 45 (19): 6085-6094	37	62	58	77
#	Date / Author / Journal	LCS	GCS	LCR	CR
431	18815 Roder HM, Hutton ML Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 APR; 11 (4): 435-442	4	6	58	78
432	20317 Cookson MR, van der Brug M Cell systems and the toxic mechanism(s) of alpha-synuclein EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 5-11	28	45	58	74
433	20606 Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations BRAIN. 2008 MAR; 131: 721-731	36	40	58	70
434	20816 Pikkarainen M, Hartikainen P, Alafuzoff I Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 APR; 67 (4): 280-298	15	16	58	85
435	21163 Schiesling C, Kieper N, Seidel K, Kruger R Review: Familial Parkinson's disease - genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 JUN; 34 (3): 255-271	12	24	58	144
436	21995 Gijselinck I, Van Broeckhoven C, Cruts M Granulin Mutations Associated With Frontotemporal Lobar Degeneration and Related Disorders: An Update HUMAN MUTATION. 2008 DEC; 29 (12): 1373-1386	16	19	58	107
437	22144 Fiala O, Ruzicka E The Genetics of Parkinson's Disease CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE. 2009; 72 (5): 419-428	0	0	58	141
438	23283 Wijeyekoon R, Barker RA Cell replacement therapy for Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 688-702	1	5	58	235
439	24408 Yeh PA, Chang CJ, Tu PH, Wilson HI, Chien JY, et al. Phosphorylation Alters Tau Distribution and Elongates Life Span in Drosophila JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (2): 543-556	0	0	58	95
440	24430 Jimenez JS Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (2): 375-391	0	0	58	223
#	Date / Author / Journal	LCS	GCS	LCR	CR
441	26885 Ando K, Leroy K, Heraud C, Yilmaz Z, Authelet M, et al. Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model AMERICAN JOURNAL OF PATHOLOGY. 2011 FEB; 178 (2): 803-816	0	0	58	77
442	7169 Tolnay M, Probst A REVIEW: tau protein pathology in Alzheimer's disease and related disorders NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 JUN; 25 (3): 171-187	77	103	57	111
443	7473 Yen SH, Hutton M, DeTure M, Ko LW, Nacharaju P Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17 BRAIN PATHOLOGY. 1999 OCT; 9 (4): 695-705	29	32	57	88
444	7938 Heininger K A unifying hypothesis of Alzheimer's disease. III. Risk factors HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2000 JAN; 15 (1): 1-70	4	21	57	1146
445	8962 Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, et al. Glycogen synthase kinase-3 beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 DEC 29; 275 (52): 41340-41349	102	148	57	81
446	10301 Riess O, Kruger R, Kobayashi H, Holzmann C, Hattori N, et al. Molecular biology of alpha-synuclein dementia with Lewy bodies - Dementia with Lewy bodies MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 497-508	0	0	57	85
447	11474 Allen B, Ingram E, Takao M, Smith MJ, Jakes R, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein JOURNAL OF NEUROSCIENCE. 2002 NOV 1; 22 (21): 9340-9351	134	148	57	75
448	11827 Verbeek MM, de Jong D, Kremer HPH Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases ANNALS OF CLINICAL BIOCHEMISTRY. 2003 JAN; 40: 25-40	17	46	57	121
449	12772 Uversky VN A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. 2003 OCT; 21 (2): 211-234	91	140	57	204
450	15781 Tofaris GK, Spillantini MG Alpha-Synuclein dysfunction in Lewy body diseases MOVEMENT DISORDERS. 2005 AUG; 20: S37-S44	25	33	57	75
#	Date / Author / Journal	LCS	GCS	LCR	CR
451	16403 Skovronsky DM, Lee VMY, Trojanowskiz JQ Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2006; 1 (1): 151-170	54	86	57	124
452	17366 Formichi P, Battisti C, Radi E, Federico A Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease JOURNAL OF CELLULAR PHYSIOLOGY. 2006 JUL; 208 (1): 39-46	13	22	57	100
453	18441 Pacher P, Beckman JS, Liaudet L Nitric oxide and peroxynitrite in health and disease PHYSIOLOGICAL REVIEWS. 2007 JAN; 87 (1): 315-424	17	591	57	1476
454	18648 Lace GL, Wharton SB, Ince PG A brief history of iota: the evolving view of the microtubule- associated protein iota in neurodegenerative diseases CLINICAL NEUROPATHOLOGY. 2007 MAR-APR; 26 (2): 43-58	3	9	57	124
455	19292 Caffrey TM, Wade-Martins R Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology NEUROBIOLOGY OF DISEASE. 2007 JUL; 27 (1): 1-10	9	9	57	76
456	19591 Sung YH, Eliezer D Residual structure, backbone dynamics, and interactions within the synuclein family JOURNAL OF MOLECULAR BIOLOGY. 2007 SEP 21; 372 (3): 689-707	15	28	57	103
457	19872 Lim KL, Tan JMM Role of the ubiquitin proteasome system in Parkinson's disease BMC BIOCHEMISTRY. 2007 NOV 22; 8: Art. No. S13	4	11	57	120
458	20042 Gupta A, Dawson VL, Dawson TM What Causes Cell Death in Parkinson's Disease? ANNALS OF NEUROLOGY. 2008; 64 (6): S3-S15	9	24	57	121
459	21415 Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ ALS and FTLD: two faces of TDP-43 proteinopathy EUROPEAN JOURNAL OF NEUROLOGY. 2008 AUG; 15 (8): 772-780	23	29	57	85
460	23075 Ninkina N, Peters O, Millership S, Salem H, van der Putten H, et al. gamma-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein HUMAN MOLECULAR GENETICS. 2009 MAY 15; 18 (10): 1779-1794	3	3	57	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
461	25247 Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease ACTA NEUROPATHOLOGICA. 2010 MAY; 119 (5): 523-541	0	4	57	212
462	26630 Pienaar IS, Gotz J, Feany MB Parkinson's disease Insights from non-traditional model organisms PROGRESS IN NEUROBIOLOGY. 2010 DEC; 92 (4): 558-571	0	0	57	203
463	3317 SMITH C, ANDERTON BH DOROTHY-RUSSELL-MEMORIAL-LECTURE - THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE - ARE WE ANY CLOSER TO UNDERSTANDING THE NEURODEGENERATIVE PROCESS NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1994 AUG; 20 (4): 322-338	11	28	56	213
464	4076 Trojanowski JQ, Lee VMY Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases FASEB JOURNAL. 1995 DEC; 9 (15): 1570-1576	117	117	56	77
465	9413 Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, et al. Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 APR; 60 (4): 328-341	21	24	56	73
466	11363 Lotharius J, Brundin P Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2395-2407	70	100	56	179
467	11576 Lotharius J, Brundin P Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha- synuclein NATURE REVIEWS NEUROSCIENCE. 2002 DEC; 3 (12): 932-942	130	250	56	137
468	12115 Al-Chalabi A, Miller CCJ Neurofilaments and neurological disease BIOESSAYS. 2003 APR; 25 (4): 346-355	30	71	56	98
469	15507 Marin I, Vallejo J Parkinson disease: From cellular and animal models to Genomics CURRENT GENOMICS. 2005 JUN; 6 (4): 241-250	0	0	56	106
470	18361 Dickson DW, Rademakers R, Hutton ML Progressive supranuclear palsy: Pathology and genetics BRAIN PATHOLOGY. 2007 JAN; 17 (1): 74-82	21	33	56	98
#	Date / Author / Journal	LCS	GCS	LCR	CR
471	20825 Otto M, Lewczuk P, Wiltfang J Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases METHODS. 2008 APR; 44 (4): 289-298	6	16	56	136
472	21442 Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JCS, et al. Biomarkers for cognitive impairment and dementia in elderly people LANCET NEUROLOGY. 2008 AUG; 7 (8): 704-714	8	19	56	131
473	21848 Huey ED, Armstrong N, Momeni P, Grafman J Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia EXPERT OPINION ON THERAPEUTIC TARGETS. 2008 NOV; 12 (11): 1367-1376	0	0	56	110
474	21971 Sahara N, Maeda S, Takashima A Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 591-598	5	9	56	73
475	23847 Leong SL, Cappai R, Barnham KJ, Pham CLL Modulation of alpha-Synuclein Aggregation by Dopamine: A Review NEUROCHEMICAL RESEARCH. 2009 OCT; 34 (10): 1838-1846	4	5	56	79
476	24990 Blennow K, Hampel H, Weiner M, Zetterberg H Cerebrospinal fluid and plasma biomarkers in Alzheimer disease NATURE REVIEWS NEUROLOGY. 2010 MAR; 6 (3): 131-144	19	29	56	159
477	26549 Siddique MM, Tan EK Neurochemistry Changes Associated with Mutations in Familial Parkinson's Disease CURRENT MEDICINAL CHEMISTRY. 2010 DEC; 17 (35): 4378-4391	0	0	56	157
478	5382 Mattson MP Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives PHYSIOLOGICAL REVIEWS. 1997 OCT; 77 (4): 1081-1132	95	572	55	594
479	5626 Julien JP, Mushynski WE Neurofilaments in health and disease PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61. 1998; 61: 1-23	64	155	55	125
480	6162 Xie HQ, Litersky JM, Hartigan JA, Jope RS, Johnson GVW The interrelationship between selective tau phosphorylation and microtubule association BRAIN RESEARCH. 1998 JUL 6; 798 (1-2): 173-183	24	44	55	87
#	Date / Author / Journal	LCS	GCS	LCR	CR
481	13175 McNaught KSP Proteolytic dysfunction in neurodegenerative disorders INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 62. 2004; 62: 95-119	0	8	55	135
482	13902 Berger W, Benke T The significance of CSF findings for the diagnosis of dementia AKTUELLE NEUROLOGIE. 2004 JUN; 31 (5): 223-230	0	1	55	102
483	15284 Frasier M, Walzer M, McCarthy L, Magnuson D, Lee JM, et al. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein EXPERIMENTAL NEUROLOGY. 2005 APR; 192 (2): 274-287	29	38	55	73
484	16442 Sankaranarayanan S Genetically modified mice models for Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627	0	3	55	235
485	16504 Sharma N, Brandis KA, Herrera SK, Johnson BE, Vaidya T, et al. alpha-synuclein budding yeast model - Toxicity enhanced by impaired proteasome and oxidative stress JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 28 (2): 161-178	14	16	55	86
486	16934 de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies ACTA NEUROPATHOLOGICA. 2006 APR; 111 (4): 329-340	25	27	55	66
487	16997 Farrer MJ Genetics of Parkinson disease: paradigm shifts and future prospects NATURE REVIEWS GENETICS. 2006 APR; 7 (4): 306-318	89	228	55	141
488	17686 Fink AL The aggregation and fibrillation of alpha-synuclein ACCOUNTS OF CHEMICAL RESEARCH. 2006 SEP 19; 39 (9): 628-634	53	84	55	68
489	17849 Croisier E, Graeber MB Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 517-530	15	37	55	165
490	19922 Lim KL Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies EXPERT REVIEW OF PROTEOMICS. 2007 DEC; 4 (6): 769-781	10	23	55	140
#	Date / Author / Journal	LCS	GCS	LCR	CR
491	20156 Iijima K, Iijima-Ando K Drosophila Models of Alzheimer's Amyloidosis: The Challenge of Dissecting the Complex Mechanisms of Toxicity of Amyloid-beta 42 JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 523-540	6	9	55	173
492	21961 Strnad R, Zatloukal K, Stumptner C, Kulaksiz H, Denk H Mallory-Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 DEC; 1782 (12): 764-774	0	10	55	155
493	25180 Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy NEUROPATHOLOGY. 2010 APR; 30 (2): 170-181	1	1	55	77
494	25184 Rogers N, Paine S, Bedford L, Layfield R Review: The ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 113-124	0	1	55	99
495	25736 Gomez A, Ferrer I Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 155-167	1	1	55	73
496	26573 See TM, LaMarre AK, Lee SE, Miller BL Genetic Causes of Frontotemporal Degeneration JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 260-268	0	0	55	84
497	5573 Brion JP Neurofibrillary tangles and Alzheimer's disease EUROPEAN NEUROLOGY. 1998; 40 (3): 130-140	7	16	54	115
498	7780 Cummings CJ, Zoghbi HY Trinucleotide repeats: Mechanisms and pathophysiology ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS. 2000; 1: 281-328	26	170	54	296
499	8811 Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, et al. Tau gene mutation K257T causes a tauopathy similar to Pick's disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 NOV; 59 (11): 990-1001	98	100	54	61
500	8841 Ninkina NN, Buchman VL Synucleins: To have or not to have? RUSSIAN JOURNAL OF GENETICS. 2000 NOV; 36 (11): 1249-1253	0	0	54	61

Date / Author / Journal

401

Hsp70 Molecular Chaperones and Parkinson's Disease

BIOPOLYMERS. 2010 MAR; 93 (3): 218-228

111

402

25681 Goedert M, Clavaguera F, Tolnay M

The propagation of prion-like protein inclusions in neurodegenerative diseases

TRENDS IN NEUROSCIENCES. 2010 JUL; 33 (7): 317-325

109

403

4079 Wischik CM, Harrington CR, Mena R

Molecular determinants of paired helical filament assembly and its therapeutic implications in Alzheimer's disease

INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 299-338

212

404

7818 Heutink P

Untangling tau-related dementia

HUMAN MOLECULAR GENETICS. 2000; 9 (6): 979-986

405

10108 Lee MK, Price DL

Advances in genetic models of Parkinson's disease

CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 456-466

178

406

10858 Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, et al.

Regulation of tau phosphorylation and protection against beta-amyloid- induced neurodegeneration by lithium. Possible implications for Alzheimer's disease

BIPOLAR DISORDERS. 2002 JUN; 4 (3): 153-165

135

407

13249 Palomo T, Archer T, Beninger RJ, Kostrzewa RM

Gene-environment interplay in Neurogenesis and neurodegeneration

NEUROTOXICITY RESEARCH. 2004; 6 (6): 415-434

309

408

18154 Windisch M, Wolf HJ, Hutter-Paier B, Wronski R

Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

CURRENT ALZHEIMER RESEARCH. 2007; 4 (5): 556-561

409

21616 Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, et al.

Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases

PLOS ONE. 2008 SEP 4; 3 (9): Art. No. e3135

113

410

23528 Schapira AHV

Etiology and Pathogenesis of Parkinson Disease

NEUROLOGIC CLINICS. 2009 AUG; 27 (3): 583-+

182

Date / Author / Journal

LCS

GCS

LCR

411

24308 Lovestone S, Killick R

Is Alzheimer's a Disorder of Ageing and Why Don't Mice get it? The Centrality of Insulin Signalling to Alzheimer's Disease Pathology

DIABETES, INSULIN AND ALZHEIMER'S DISEASE. 2010; : 129-152

157

412

24406 Amadoro G, Corsetti V, Stringaro A, Colone M, D'Aguanno S, et al.

A NH2 Tau Fragment Targets Neuronal Mitochondria at AD Synapses: Possible Implications for Neurodegeneration

JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (2): 445-470

173

413

25225 Ramsey CP, Tsika E, Ischiropoulos H, Giasson BI

DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity

HUMAN MOLECULAR GENETICS. 2010 APR 15; 19 (8): 1425-1437

106

414

3010 Trojanowski JQ, Lee VMY

PHOSPHORYLATION OF NEURONAL CYTOSKELETAL PROTEINS IN ALZHEIMERS-DISEASE AND LEWY BODY DEMENTIAS

CALCIUM HYPOTHESIS OF AGING AND DEMENTIA. 1994; 747: 92-109

111

415

10270 Kowalska A

Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

FOLIA NEUROPATHOLOGICA. 2002; 40 (3): 111-118

416

11314 Echeverria V, Cuello AC

Intracellular A-beta amyloid, a sign for worse things to come?

MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 299-316

188

417

11666 Bonini NM, Fortini ME

Human neurodegenerative disease modeling using Drosophila

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656

178

418

12129 Kaplan B, Ratner V, Haas E

alpha-Synuclein - Its biological function and role in neurodegenerative diseases

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003 APR; 20 (2): 83-92

419

12874 Dawson TM, Dawson VL

Molecular pathways of neurodegeneration in Parkinson's disease

SCIENCE. 2003 OCT 31; 302 (5646): 819-822

220

603

420

13098 Sobow T, Flirski M, Liberski PP

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease

ACTA NEUROBIOLOGIAE EXPERIMENTALIS. 2004; 64 (1): 53-70

141

Date / Author / Journal

LCS

GCS

LCR

421

13867 Uversky VN, Fink AL

Conformational constraints for amyloid fibrillation: the importance of being unfolded

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2004 MAY 6; 1698 (2): 131-153

384

301

422

13955 Zhang J, Goodlett DR

Proteomic approach to studying Parkinson's disease

MOLECULAR NEUROBIOLOGY. 2004 JUN; 29 (3): 271-288

171

423

14970 Lim JN, Lu KP

Pinning down phosphorylated tau and tauopathies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 311-322

129

424

15140 Maingay M, Romero-Ramos M, Kirik D

Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: A new model for Parkinson's disease

CNS SPECTRUMS. 2005 MAR; 10 (3): 235-244

425

15370 Fornai F, Soldani P, Lazzeri G, di Poggio AB, Biagioni F, et al.

Neuronal inclusions in degenerative disorders - Do they represent static features or a key to understand the dynamics of the disease?

BRAIN RESEARCH BULLETIN. 2005 APR 30; 65 (4): 275-290

133

426

15565 Hoerndli F, David DC, Gotz J

Functional genomics meets neurodegenerative disorders Part II: Application and data integration

PROGRESS IN NEUROBIOLOGY. 2005 JUN; 76 (3): 169-188

146

427

16159 Neary D, Snowden J, Mann D

Frontotemporal dementia

LANCET NEUROLOGY. 2005 NOV; 4 (11): 771-780

132

141

428

16208 Shults CW, Rockenstein E, Crews L, Adame A, Mante M, et al.

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: Implications for multiple system atrophy

JOURNAL OF NEUROSCIENCE. 2005 NOV 16; 25 (46): 10689-10699

429

16870 Abou-Sleiman PM, Muqit MMK, Wood NW

Expanding insights of mitochondrial dysfunction in Parkinson's disease

NATURE REVIEWS NEUROSCIENCE. 2006 MAR; 7 (3): 207-219

246

142

430

17177 Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, et al.

Small molecule inhibitors of alpha-synuclein filament assembly

BIOCHEMISTRY. 2006 MAY 16; 45 (19): 6085-6094

Date / Author / Journal

LCS

GCS

LCR

431

18815 Roder HM, Hutton ML

Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease

EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 APR; 11 (4): 435-442

432

20317 Cookson MR, van der Brug M

Cell systems and the toxic mechanism(s) of alpha-synuclein

EXPERIMENTAL NEUROLOGY. 2008 JAN; 209 (1): 5-11

433

20606 Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, et al.

Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations

BRAIN. 2008 MAR; 131: 721-731

434

20816 Pikkarainen M, Hartikainen P, Alafuzoff I

Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 APR; 67 (4): 280-298

435

21163 Schiesling C, Kieper N, Seidel K, Kruger R

Review: Familial Parkinson's disease - genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 JUN; 34 (3): 255-271

144

436

21995 Gijselinck I, Van Broeckhoven C, Cruts M

Granulin Mutations Associated With Frontotemporal Lobar Degeneration and Related Disorders: An Update

HUMAN MUTATION. 2008 DEC; 29 (12): 1373-1386

107

437

22144 Fiala O, Ruzicka E

The Genetics of Parkinson's Disease

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE. 2009; 72 (5): 419-428

141

438

23283 Wijeyekoon R, Barker RA

Cell replacement therapy for Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 688-702

235

439

24408 Yeh PA, Chang CJ, Tu PH, Wilson HI, Chien JY, et al.

Phosphorylation Alters Tau Distribution and Elongates Life Span in Drosophila

JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (2): 543-556

440

24430 Jimenez JS

Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis

JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (2): 375-391

223

Date / Author / Journal

LCS

GCS

LCR

441

26885 Ando K, Leroy K, Heraud C, Yilmaz Z, Authelet M, et al.

Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model

AMERICAN JOURNAL OF PATHOLOGY. 2011 FEB; 178 (2): 803-816

442

7169 Tolnay M, Probst A

REVIEW: tau protein pathology in Alzheimer's disease and related disorders

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 JUN; 25 (3): 171-187

103

111

443

7473 Yen SH, Hutton M, DeTure M, Ko LW, Nacharaju P

Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 695-705

444

7938 Heininger K

A unifying hypothesis of Alzheimer's disease. III. Risk factors

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2000 JAN; 15 (1): 1-70

1146

445

8962 Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, et al.

Glycogen synthase kinase-3 beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice

JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 DEC 29; 275 (52): 41340-41349

102

148

446

10301 Riess O, Kruger R, Kobayashi H, Holzmann C, Hattori N, et al.

Molecular biology of alpha-synuclein dementia with Lewy bodies - Dementia with Lewy bodies

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 497-508

447

11474 Allen B, Ingram E, Takao M, Smith MJ, Jakes R, et al.

Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein

JOURNAL OF NEUROSCIENCE. 2002 NOV 1; 22 (21): 9340-9351

134

148

448

11827 Verbeek MM, de Jong D, Kremer HPH

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases

ANNALS OF CLINICAL BIOCHEMISTRY. 2003 JAN; 40: 25-40

121

449

12772 Uversky VN

A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. 2003 OCT; 21 (2): 211-234

140

204

450

15781 Tofaris GK, Spillantini MG

Alpha-Synuclein dysfunction in Lewy body diseases

MOVEMENT DISORDERS. 2005 AUG; 20: S37-S44

Date / Author / Journal

LCS

GCS

LCR

451

16403 Skovronsky DM, Lee VMY, Trojanowskiz JQ

Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2006; 1 (1): 151-170

124

452

17366 Formichi P, Battisti C, Radi E, Federico A

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease

JOURNAL OF CELLULAR PHYSIOLOGY. 2006 JUL; 208 (1): 39-46

100

453

18441 Pacher P, Beckman JS, Liaudet L

Nitric oxide and peroxynitrite in health and disease

PHYSIOLOGICAL REVIEWS. 2007 JAN; 87 (1): 315-424

591

1476

454

18648 Lace GL, Wharton SB, Ince PG

A brief history of iota: the evolving view of the microtubule- associated protein iota in neurodegenerative diseases

CLINICAL NEUROPATHOLOGY. 2007 MAR-APR; 26 (2): 43-58

124

455

19292 Caffrey TM, Wade-Martins R

Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology

NEUROBIOLOGY OF DISEASE. 2007 JUL; 27 (1): 1-10

456

19591 Sung YH, Eliezer D

Residual structure, backbone dynamics, and interactions within the synuclein family

JOURNAL OF MOLECULAR BIOLOGY. 2007 SEP 21; 372 (3): 689-707

103

457

19872 Lim KL, Tan JMM

Role of the ubiquitin proteasome system in Parkinson's disease

BMC BIOCHEMISTRY. 2007 NOV 22; 8: Art. No. S13

120

458

20042 Gupta A, Dawson VL, Dawson TM

What Causes Cell Death in Parkinson's Disease?

ANNALS OF NEUROLOGY. 2008; 64 (6): S3-S15

121

459

21415 Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ

ALS and FTLD: two faces of TDP-43 proteinopathy

EUROPEAN JOURNAL OF NEUROLOGY. 2008 AUG; 15 (8): 772-780

460

23075 Ninkina N, Peters O, Millership S, Salem H, van der Putten H, et al.

gamma-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein

HUMAN MOLECULAR GENETICS. 2009 MAY 15; 18 (10): 1779-1794

Date / Author / Journal

LCS

GCS

LCR

461

25247 Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E

Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease

ACTA NEUROPATHOLOGICA. 2010 MAY; 119 (5): 523-541

212

462

26630 Pienaar IS, Gotz J, Feany MB

Parkinson's disease Insights from non-traditional model organisms

PROGRESS IN NEUROBIOLOGY. 2010 DEC; 92 (4): 558-571

203

463

3317 SMITH C, ANDERTON BH

DOROTHY-RUSSELL-MEMORIAL-LECTURE - THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE - ARE WE ANY CLOSER TO UNDERSTANDING THE NEURODEGENERATIVE PROCESS

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1994 AUG; 20 (4): 322-338

213

464

4076 Trojanowski JQ, Lee VMY

Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases

FASEB JOURNAL. 1995 DEC; 9 (15): 1570-1576

117

465

9413 Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, et al.

Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 APR; 60 (4): 328-341

466

11363 Lotharius J, Brundin P

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease

HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2395-2407

100

179

467

11576 Lotharius J, Brundin P

Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha- synuclein

NATURE REVIEWS NEUROSCIENCE. 2002 DEC; 3 (12): 932-942

130

250

137

468

12115 Al-Chalabi A, Miller CCJ

Neurofilaments and neurological disease

BIOESSAYS. 2003 APR; 25 (4): 346-355

469

15507 Marin I, Vallejo J

Parkinson disease: From cellular and animal models to Genomics

CURRENT GENOMICS. 2005 JUN; 6 (4): 241-250

106

470

18361 Dickson DW, Rademakers R, Hutton ML

Progressive supranuclear palsy: Pathology and genetics

BRAIN PATHOLOGY. 2007 JAN; 17 (1): 74-82

Date / Author / Journal

LCS

GCS

LCR

471

20825 Otto M, Lewczuk P, Wiltfang J

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases

METHODS. 2008 APR; 44 (4): 289-298

136

472

21442 Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JCS, et al.

Biomarkers for cognitive impairment and dementia in elderly people

LANCET NEUROLOGY. 2008 AUG; 7 (8): 704-714

131

473

21848 Huey ED, Armstrong N, Momeni P, Grafman J

Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia

EXPERT OPINION ON THERAPEUTIC TARGETS. 2008 NOV; 12 (11): 1367-1376

110

474

21971 Sahara N, Maeda S, Takashima A

Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration

CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 591-598

475

23847 Leong SL, Cappai R, Barnham KJ, Pham CLL

Modulation of alpha-Synuclein Aggregation by Dopamine: A Review

NEUROCHEMICAL RESEARCH. 2009 OCT; 34 (10): 1838-1846

476

24990 Blennow K, Hampel H, Weiner M, Zetterberg H

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

NATURE REVIEWS NEUROLOGY. 2010 MAR; 6 (3): 131-144

159

477

26549 Siddique MM, Tan EK

Neurochemistry Changes Associated with Mutations in Familial Parkinson's Disease

CURRENT MEDICINAL CHEMISTRY. 2010 DEC; 17 (35): 4378-4391

157

478

5382 Mattson MP

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

PHYSIOLOGICAL REVIEWS. 1997 OCT; 77 (4): 1081-1132

572

594

479

5626 Julien JP, Mushynski WE

Neurofilaments in health and disease

PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61. 1998; 61: 1-23

155

125

480

6162 Xie HQ, Litersky JM, Hartigan JA, Jope RS, Johnson GVW

The interrelationship between selective tau phosphorylation and microtubule association

BRAIN RESEARCH. 1998 JUL 6; 798 (1-2): 173-183

Date / Author / Journal

481

Proteolytic dysfunction in neurodegenerative disorders

INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 62. 2004; 62: 95-119

135

482

13902 Berger W, Benke T

The significance of CSF findings for the diagnosis of dementia

AKTUELLE NEUROLOGIE. 2004 JUN; 31 (5): 223-230

102

483

15284 Frasier M, Walzer M, McCarthy L, Magnuson D, Lee JM, et al.

Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein

EXPERIMENTAL NEUROLOGY. 2005 APR; 192 (2): 274-287

484

16442 Sankaranarayanan S

Genetically modified mice models for Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627

235

485

16504 Sharma N, Brandis KA, Herrera SK, Johnson BE, Vaidya T, et al.

alpha-synuclein budding yeast model - Toxicity enhanced by impaired proteasome and oxidative stress

JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 28 (2): 161-178

486

16934 de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, et al.

An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies

ACTA NEUROPATHOLOGICA. 2006 APR; 111 (4): 329-340

487

16997 Farrer MJ

Genetics of Parkinson disease: paradigm shifts and future prospects

NATURE REVIEWS GENETICS. 2006 APR; 7 (4): 306-318

228

141

488

17686 Fink AL

The aggregation and fibrillation of alpha-synuclein

ACCOUNTS OF CHEMICAL RESEARCH. 2006 SEP 19; 39 (9): 628-634

489

17849 Croisier E, Graeber MB

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 517-530

165

490

19922 Lim KL

Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies

EXPERT REVIEW OF PROTEOMICS. 2007 DEC; 4 (6): 769-781

140

Date / Author / Journal

LCS

GCS

LCR

491

20156 Iijima K, Iijima-Ando K

Drosophila Models of Alzheimer's Amyloidosis: The Challenge of Dissecting the Complex Mechanisms of Toxicity of Amyloid-beta 42

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 523-540

173

492

21961 Strnad R, Zatloukal K, Stumptner C, Kulaksiz H, Denk H

Mallory-Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 DEC; 1782 (12): 764-774

155

493

25180 Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, et al.

Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy

NEUROPATHOLOGY. 2010 APR; 30 (2): 170-181

494

25184 Rogers N, Paine S, Bedford L, Layfield R

Review: The ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 113-124

495

25736 Gomez A, Ferrer I

Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment

ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 155-167

496

26573 See TM, LaMarre AK, Lee SE, Miller BL

Genetic Causes of Frontotemporal Degeneration

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 260-268

497

5573 Brion JP

Neurofibrillary tangles and Alzheimer's disease

EUROPEAN NEUROLOGY. 1998; 40 (3): 130-140

115

498

7780 Cummings CJ, Zoghbi HY

Trinucleotide repeats: Mechanisms and pathophysiology

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS. 2000; 1: 281-328

170

296

499

8811 Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, et al.

Tau gene mutation K257T causes a tauopathy similar to Pick's disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 NOV; 59 (11): 990-1001

100

500

8841 Ninkina NN, Buchman VL

Synucleins: To have or not to have?

RUSSIAN JOURNAL OF GENETICS. 2000 NOV; 36 (11): 1249-1253

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records